Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,713 | -6,193 | -16,743 | -13,028 | -7,576 |
| Depreciation Amortization | 1,207 | 604 | 2,104 | 1,538 | 974 |
| Accounts receivable | -2,193 | -608 | -2,798 | -1,069 | 10 |
| Accounts payable and accrued liabilities | 607 | 550 | -1,522 | 702 | 721 |
| Other Working Capital | -2,752 | -1,488 | -11,628 | -6,481 | -4,837 |
| Other Operating Activity | 3,762 | 1,106 | 7,493 | 2,856 | 613 |
| Operating Cash Flow | $-10,082 | $-6,029 | $-23,094 | $-15,482 | $-10,095 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | N/A | 5,000 | N/A | N/A |
| PPE Investments | 7,164 | 2,689 | 734 | -879 | -529 |
| Purchase Of Investment | N/A | N/A | -9,964 | -9,964 | -9,964 |
| Purchase Sale Intangibles | -19 | -10 | -101 | -83 | -57 |
| Other Investing Activity | -19 | -10 | -101 | -83 | -57 |
| Investing Cash Flow | $12,145 | $2,679 | $-4,331 | $-10,926 | $-10,550 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | 25,000 | 25,000 | 25,000 |
| Common Stock Issued | 291 | 28 | 1,816 | 1,670 | 1,590 |
| Other Financing Activity | -135 | -130 | -543 | -542 | -241 |
| Financing Cash Flow | $156 | $-102 | $26,273 | $26,128 | $26,349 |
| Exchange Rate Effect | 1 | 1 | -1 | -1 | -1 |
| Beginning Cash Position | 26,562 | 26,562 | 27,715 | 27,715 | 27,715 |
| End Cash Position | 28,782 | 23,111 | 26,562 | 27,434 | 33,418 |
| Net Cash Flow | $2,220 | $-3,451 | $-1,153 | $-281 | $5,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,082 | -6,029 | -23,094 | -15,482 | -10,095 |
| Capital Expenditure | -336 | -61 | -1,167 | -879 | -529 |
| Free Cash Flow | -10,418 | -6,090 | -24,261 | -16,361 | -10,624 |